Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress
Business Wire (Mon, 10-Aug 4:00 PM ET)
Business Wire (Mon, 3-Aug 7:00 AM ET)
Business Wire (Fri, 12-Jun 7:00 AM ET)
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Business Wire (Thu, 28-May 7:00 AM ET)
Market Chameleon (Fri, 27-Mar 3:05 AM ET)
Market Chameleon (Fri, 27-Feb 5:34 AM ET)
Market Chameleon (Tue, 14-Oct 7:18 AM ET)
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Rocket Pharmaceuticals trades on the NASDAQ stock market under the symbol RCKT.
As of August 19, 2026, RCKT stock price climbed to $3.64 with 1,347,308 million shares trading.
RCKT has a beta of 2.36, meaning it tends to be more sensitive to market movements. RCKT has a correlation of 0.17 to the broad based SPY ETF.
RCKT has a market cap of $399.58 million. This is considered a Small Cap stock.
Last quarter Rocket Pharmaceuticals reported $0 in Revenue and -$.37 earnings per share. This fell short of revenue expectation by $-13 million and missed earnings estimates by -$.71.
In the last 3 years, RCKT traded as high as $32.53 and as low as $2.19.
The top ETF exchange traded funds that RCKT belongs to (by Net Assets): VTI, IWM, VXF, FESM, IWN.
RCKT has underperformed the market in the last year with a return of +20.1%, while SPY returned +20.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RCKT shares. However, RCKT has outperformed the market in the last 3 month and 2 week periods, returning +18.6% and +5.8%, while SPY returned +4.4% and -0.3%, respectively. This indicates RCKT has been having a stronger performance recently.
RCKT support price is $3.22 and resistance is $3.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RCKT shares will trade within this expected range on the day.